Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Neuropathic pain following nerve damage, whether from physical, chemical, metabolic, infection or other reasons, infrequently responds to conventional analgesics. The anti-epileptic agent GBP, however, has manifested consistent analgesic efficacy in animal models of neuropathic pain [9, 10] and also in patients with chronic pain of this type [39]. In the present study, we were able to observe a reduction of neuropathic pain after intraperitoneal administration of gabapentin in CCI rats. The upregulation of pCaMKII and tCaMKII was maintained until 10 days after CCI, which suggested that CaMKII is involved in the generation and maintenance of neuropathic pain after CCI. Gabapentin is an anti-epileptic agent but now it is also recommended as first line agent in neuropathic pain, particularly in diabetic neuropathy and post herpetic neuralgia. α2δ-1, an auxillary subunit of voltage gated calcium channels, has been documented as its main target and its specific binding to this subunit is described to produce different actions responsible for pain attenuation In a previous study, gabapentin has shown analgesic effects in the rat chronic constriction injury model of neuropathic pain [Citation 25]. In parallel, both pyrimidine nucleotide family members, uridine and cytidine, are essential in cellular metabolism and involved in energy transfer, neurotransmission, and biochemical radical transfer In order to master more accurate information in the treatment of human nerve tissue and improve the efficiency of treatment, this paper discusses the antagonistic effect of gabapentin on neuropathic pain in rats through the p38 MAPK signal pathway. To evaluate the effect of Gabapentin and Pregabalin in Paclitaxel (Taxol) induced neuropathic pain and to compare the effect of these drugs in animal models. Rats were randomly divided into four groups of six animals each. To determine whether gabapentin alleviates affective pain after traumatic nerve injury, we assessed CPP in sham and SNI rats. Fig 3A illustrates our biased conditioning approach: preconditioning time spent in the saline-paired chamber was greater than time spent in the gabapentin-paired chamber in both sham [p < 0.05] and SNI [p < 0.0001] rats. This study evaluates the contribution of inhibitory pain pathways that descend to the spinal cord through the dorsolateral funiculus (DLF) on the effect of intrathecal gabapentin against spinal nerve ligation (SNL)-induced behavioral hypersensitivity to mechanical stimulation in rats. Gabapentin (GBP) is an anti-convulsive drug often used as analgesic to control neuropathic pain. This study aimed at evaluating oral GBP treatment (30, 60, 120 mg/kg, 60 min prior to chronic constriction of the sciatic nerve (CCSN) along 15-day treatment post-injury, 12 h/12 h) by monitoring spontan Neuropathic pain, defined by the Neuropathic Pain Special Interest Group (NeuPSIG) as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system,” is a serious and intractable condition, which has been linked to reactive oxygen species (ROS), a group of highly active molecules [1], [2]. Neuropathic pain; CCI; diabetes; gabapentin; pregabalin Introduction Diabetic neuropathy is the most common complication of diabetes type 1 and type 2 and as many as 50% of patients develop neuropathy in the course of the disease [1]. According to a definition of the Special Interest Group on Neuropathic Pain (NeuPSIG), neuropathic pain Gabapentin is a first-line therapy for neuropathic pain but its mechanisms and sites of action remain uncertain. We investigated gabapentin-induced modulation of neuropathic pain following spinal nerve ligation (SNL) in rats. We examined the possible anti-inflammatory mechanisms of gabapentin in the attenuation of neuropathic pain and the interaction between the anti-allodynic effects of gabapentin and interleukin-10 (IL-10) expression in a rat model of neuropathic pain. The anti-allodynic effect of intrathecal gabapentin was examined over a 7-day period. Gabapentin (60 mg/kg) and pregabalin (30 mg/kg) attenuate mechanical, tactile and heat hypersensitivity in rats with chronic constriction injury of the sciatic nerve and streptozotocin (STZ)-induced diabetes. There is no evidence that one of the drugs is superior to another at the different rat models and tests. Gabapentin (GBP) ameliorates paw withdrawal thresholds (PWT) in neuropathic pain model rats, although it does not influence the PWT in response to mechanical stimuli in naive rats. (A) Naive rats were intraperitoneally administered 100 mg/kg GBP, and PWT was measured 120 min after GBP administration. In conclusion, gabapentin is shown to be safe at therapeutic dosing and exhibits beneficial effects with regard to neuropathic pain, and while not considered a first-choice treatment of seizures in the pet rat, it has shown to be useful as an additive therapy where seizures are refractory to the use of conventional seizure medications. In this study, we addressed GBP effects on neuropathic pain behavior (5th and 15th day post-sciatic ligature) and on nerve myelination parameters following chronic sciatic nerve constriction in rats. Methods: The adult rats were randomly divided into 4 groups: A sham operation (Sham) group, a comorbidity model+normal saline (CCI+Veh) group (1 mL saline), a comorbidity model+low-dose gabapentin (CCI+LG) group (diluting gabapentin with normal saline to 1 mL at the dose of 30 mg/kg), and a comorbidity model+high-dose gabapentin (CCI+HG) group Gabapentin treatment restored the reduction in the pain threshold caused by MeHg exposure in rats. Histochemical and biochemical analyses revealed that gabapentin showed no effect on MeHg-induced neurodegeneration in entire nervous system and microglial activation in the spinal dorsal horn. Intra-LC-injected gabapentin reduced hypersensitivity in SNL rats in a dose-dependent manner. Both intra-LC coadministration of CNQX and intrathecal administration of the alpha2-adrenoceptor antagonist idazoxan blocked antihypersensitivity by intra-LC gabapentin. Intravenous gabapentin induced noradrenaline release in the spinal dorsal horn.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |